Firms
Theme

AGRO

ADECOAGRO S.A. · NYSE

News

2 latest

No direct coverage yet · Showing articles that mention AGRO

Zacks Investment Research

Archer Daniels' Wilmar Earnings Fall 22%: Is Pressure Temporary?

Archer Daniels Midland (ADM) reported a 22% year-over-year decline in equity earnings from its Wilmar International investment to $60 million in Q2 2026. While ADM's broader business benefited from stronger oilseed profits and nearly 5% growth in global processing volumes, Wilmar's weakness persisted due to commodity price fluctuations, margin pressures, and rising costs. ADM shares have gained 16.2% in the past six months and carry a Zacks Rank #1 (Strong Buy) rating.

Zacks Investment Research

Archer Daniels Surpasses 50-Day SMA: Time to Buy or Stay Cautious?

Archer Daniels Midland (ADM) has broken above its 50-day simple moving average, signaling renewed technical strength. The company raised its 2026 adjusted EPS guidance to $5.15-$5.60 from $4.15-$4.70, driven by improved crushing and ethanol economics, stronger biofuels backdrop, and accelerating Nutrition segment momentum. ADM has outperformed peers and the broader market with a 43% year-to-date gain, though it trades at a premium valuation of 14.61X forward P/E compared to the industry average of 8.06X.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AGRO · 0 threads

Sign in to post on $AGRO

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev